Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SAT1 | P21673 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.38 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.38 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.38 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 5/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13912174 | 0.98 | SAT1 (0.46) | SAT1ALDH1A1KDM4ES1PR2S1PR4 | |
| SCHEMBL19975960 | 0.97 | SAT1 (0.45) | SAT1ALDH1A1KDM4ES1PR2S1PR4 | |
| SCHEMBL18104316 | 0.90 | SAT1 (0.47) | SAT1ALDH1A1KDM4ES1PR2S1PR4 | |
| SCHEMBL13912179 | 0.88 | SAT1 (0.49) | SAT1ALDH1A1KDM4ES1PR2S1PR4 | |
| SCHEMBL16559185 | 0.88 | LPAR3 (0.45) | ALDH1A1LPAR3LPAR1LPAR2PLA2G2A | |
| SCHEMBL21257334 | 0.88 | LPAR3 (0.45) | ALDH1A1LPAR3LPAR1LPAR2PLA2G2A | |
| SCHEMBL16559186 | 0.88 | LPAR3 (0.45) | ALDH1A1LPAR3LPAR1LPAR2PLA2G2A | |
| SCHEMBL213020 | 0.88 | LPAR3 (0.45) | ALDH1A1LPAR3LPAR1LPAR2PLA2G2A | |
| SCHEMBL16938180 | 0.87 | LPAR3 (0.53) | SAT1ALDH1A1S1PR2S1PR4S1PR1 | |
| SCHEMBL14614344 | 0.86 | LPAR3 (0.42) | LPAR3LPAR1LPAR2PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676798-B2 | Cationic oligonucleotides, automated methods for preparing same and their uses | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-06-13 | — | — | US | disclosed |
| US-20160280728-A1 | CATIONIC OLIGONUCLEOTIDES, AUTOMATED METHODS FOR PREPARING SAME AND THEIR USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2016-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160280728-A1 | CATIONIC OLIGONUCLEOTIDES, AUTOMATED METHODS FOR PREPARING SAME AND THEIR USES | HNRNPH3, SRM, SNRPB2 | SAT1 1099/4885ALDH1A1 3852/4885KDM4E 2174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.